Ministry of Trade Industry and Resources

The Ministry of Trade, Industry and Resources (MOTIR, Minister JK Kim) and the Korea Biotechnology Industry Organization (KoreaBIO, President Ko Hansung) announced the results of the 2025 Bioindustry Survey (Based on 2024 Data), which covers the status of production, trade, employment, and investment in Korea’s bioindustry.

Conducted in accordance with Article 3 of the Statistics Act, the survey is a national statistical report released annually by MOTIR through KoreaBIO, based on the previous year’s bioindustry performance. As biotechnology expands beyond pharmaceuticals and food into broader industrial applications and daily life, ushering in the era of the bioeconomy, this survey provides valuable insight into the scale of Korea’s biotechnology-based economy.

According to the findings, Korea’s bioindustry production reached KRW 22.9 trillion, marking a 9.8 percent increase from the previous year and signaling a recovery in growth. Bioindustry exports rose 17.1 percent year-on-year, driven by increased shipments of major products such as antibody drugs and biopharmaceutical contract manufacturing (CMO) services, boosting overall production. Total investment also surged 46.1 percent, with R&D spending up 3.2 percent and large-scale facility investment up 145.3 percent.

Choi Woo-hyuk, Director General for Advanced Industry Policy at MOTIR, stated, “Despite ongoing uncertainty in the global trade environment, Korea’s bioindustry is regaining momentum. We will continue to strengthen support for companies’ efforts in research and development, production, and export expansion so that the bioindustry can contribute more to the Korean economy and employment.”